Company attributes
Location
B2X
Pitchbook URL
Date Incorporated
March 27, 2012
Full Address
1951 North West 7th Avenue Suite 300 Miami, FL 33136 United States
CIK Number
Total Funding Amount (USD)
300,000
Latest Funding Round Date
August 2014
Latest Funding Type
Other attributes
Company Operating Status
Closed
Integene International LLC. has developed platform technology for diabetes and it's complications. Targets include Peripheral Artery Disease (PAD) Obesity and Hyperglycemia. Integene International has developed a protocol, GenstemX, for the treatment of Ischemic diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
